The concept of targeted gene therapy has led to much promise in the treatment of cancer based on genotype. Methods for assaying specimens comprehensively and cost-effectively will undoubtedly be an important step towards this paradigm shift in treatment. I was wondering if Dr. Pritchard, who together with colleagues developed a clinical molecular diagnostic assay for this aim, could speak more on this topic, particularly as it pertains to the promise and future use of such tools. I invite our other panelists to comment as well!
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.